We have recently discussed the new anticoagulants for stroke prevention in atrial fibrillation. MedPage Today has recently posted this excellent video review of these new anticoagulants. The key principles are as follows:
– Atrial fibrillation is a common cause of stroke and there are effective therapies that can prevent this sequelae
– The new therapies for atrial fibrillation, which include dabigatran, rivaroxaban, and apixaban are as good or even better than the traditional warfarin therapy at stroke prevention
– The new anticoagulants have a wide therapeutic range and do not require monitoring of the INR for a narrow goal therapeutic range
See the Medpage Today Video Review below:
DrSamGirgis.com is a blog about medicine, nutrition, health, wellness, and breaking medical news. At DrSamGirgis.com, the goal is to provide a forum for discussion on health and wellness topics and to provide the latest medical research findings and breaking medical news commentary.
{ 0 comments… add one now }